Shares of Sanofi ADR
were up 1% in trading on Monday after the French drugmaker announced plans to work on a vaccine for COVID-19, the new coronavirus that has sickened more than 73,000 people and led to the deaths of 1,873. The company said it will leverage previous work on a pre-clinical vaccine for severe acute respiratory syndrome (SARS) while it collaborates with the Biomedical Advanced Research and Development Authority (BARDA) on a COVID-19 vaccine. COVID-19 and SARS are both coronaviruses. A number of large drugmakers including GlaxoSmithKline and Johnson & Johnson have said they are also working on vaccines for the virus. Sanofi’s stock is up 19% over the past year, while the S&P 500
has gained 23%.
#div-gpt-ad-1569967089584-0 > div > iframe width: 100% !important; min-width: 300px; max-width: 800px;
